Physician
Manzoor Kazi Medical Associates INC
Manzoor Kazi Medical Associates INC was paid $7.80M by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoMANZOOR KAZI MEDICAL ASSOCIATES INC
PALM DESERT, CA 92260
PALM DESERT, CA 92260
33aNPI1003849621assigned 07/08/2006
33bProvider typeInternal Medicine Physician
28Total paid$7.80M
24GClaims86,071
24DCodes billed59
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#16 of 2,679
Median peer was paid$13K
This provider vs. median619×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,387 | $921K | |
| 2019 | 10,028 | $976K | |
| 2020 | 10,092 | $995K | |
| 2021 | 12,645 | $1.26M | |
| 2022 | 15,343 | $1.39M | |
| 2023 | 13,087 | $1.16M | |
| 2024incomplete | 16,489 | $1.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 32,011 | 24,490 | $3.63M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 22% | 10,877 | 9,773 | $1.69M |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 9.5% | 6,040 | 5,951 | $744K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 6.9% | 3,243 | 3,186 | $537K |
| 99205 | Prolong outpt/office vis | 4.5% | 1,870 | 1,786 | $355K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 2.6% | 7,733 | 6,524 | $199K |
| S9083 | Global fee urgent care centers | 2.4% | 2,428 | 2,047 | $189K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.1% | 1,015 | 946 | $84K |
| G0444 | Annual depression screening, 5 to 15 minutes | 1.0% | 4,637 | 4,584 | $81K |
| 99407 | <1% | 2,341 | 2,126 | $68K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 406 | 393 | $61K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 3,563 | 2,965 | $43K |
47 more codes
| 99495 | <1% | 97 | $19K | |
| 99406 | <1% | 1,003 | $15K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 330 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 896 | $12K |
| 99490 | Ccm add 20min | <1% | 1,482 | $11K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 252 | $10K |
| 99421 | <1% | 594 | $9K | |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans | <1% | 119 | $7K |
| 99408 | <1% | 140 | $5K | |
| 90674 | <1% | 171 | $5K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 415 | $3K |
| G0008 | Administration of influenza virus vaccine | <1% | 102 | $2K |
| 99423 | <1% | 32 | $1K | |
| 90658 | <1% | 78 | $1K | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | <1% | 137 | $1K |
| 99422 | <1% | 40 | $1K | |
| 93000 | <1% | 78 | $1K | |
| 94680 | <1% | 13 | $1K | |
| 81000 | <1% | 283 | $1K | |
| 88141 | <1% | 51 | $868.02 | |
| 99497 | <1% | 31 | $838.78 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 33 | $660.00 |
| 99439 | <1% | 271 | $611.85 | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 45 | $509.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 21 | $443.82 |
| 96160 | <1% | 460 | $396.65 | |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | <1% | 12 | $395.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,044 | $368.68 |
| 99454 | <1% | 29 | $325.15 | |
| 99457 | <1% | 29 | $252.57 | |
| 99458 | <1% | 30 | $202.24 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 137 | $133.09 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 240 | $58.76 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 29 | $46.11 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $2.54 |
| 1160F | 0% | 133 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 234 | $0.00 |
| 3078F | 0% | 222 | $0.00 | |
| 4004F | 0% | 34 | $0.00 | |
| 3077F | 0% | 24 | $0.00 | |
| 3008F | 0% | 116 | $0.00 | |
| 3044F | 0% | 88 | $0.00 | |
| 3074F | 0% | 237 | $0.00 | |
| 1111F | 0% | 25 | $0.00 | |
| 1036F | 0% | 19 | $0.00 | |
| 3079F | 0% | 27 | $0.00 | |
| 3075F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAZI, MANZOOR (CEO)